Disease Outbreak News
London/Geneva: The United Kingdom has reported severe acute cases of hepatitis of unknown aetiology from 10 on April 5, 2022, to 74 such cases on April 8, 2022.
On April 5, the International Health Regulations (IHR) National Focal Point (NFP) for the United Kingdom notified the World Health Organization (WHO) of 10 cases of severe acute hepatitis of unknown aetiology in previously healthy young children (age range: 11 months to five-year-old) across central Scotland. Of these 10 cases, nine had an onset of symptoms in March 2022 while one case had an onset of symptoms in January 2022. Symptoms included jaundice, diarrhoea, vomiting and abdominal pain. All 10 cases were detected when hospitalised.
As of April 8, 2022, further investigations across the United Kingdom identified a total of 74 cases (including the 10 cases). The clinical syndrome in identified cases is of acute hepatitis with markedly elevated liver enzymes, often with jaundice, sometimes preceded by gastrointestinal symptoms, in children principally up to 10 years old.
Some cases have required transfer to specialist children’s liver units and six children have undergone liver transplantation. As of April 11, no death was reported among these cases and one epidemiologically linked case was detected.
Hepatitis viruses (A, B, C, E, and D where applicable) have been excluded after laboratory testing while further investigations are ongoing to understand the aetiology of these cases. Given the increase in cases reported over the past one month and enhanced case search activities, more cases are likely to be reported in the coming days.
Description of cases
Laboratory testing has excluded hepatitis type A, B, C, and E viruses (and D where applicable) in these cases while severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and/or adenovirus have been detected in several cases.
The United Kingdom has recently observed an increase in adenovirus activity, which is co-circulating with SARS-CoV-2, though the role of these viruses in the pathogenesis (the mechanism by which disease develops) is not yet clear. No other epidemiological risk factors have been identified to date, including recent international travel.
Overall, the aetiology of the current hepatitis cases is still considered unknown and remains under active investigation. Laboratory testing for additional infections, chemicals and toxins was underway for the identified cases.
Following the notification from the UK, less than five cases (confirmed or possible) had been reported in Ireland, and further investigations into these were ongoing. Additionally, three confirmed cases of acute hepatitis of unknown aetiology had been reported in children (age range 22-month-old to 13-year-old) in Spain. The national authorities are currently investigating these cases.
Clinical and public health response has been implemented across the United Kingdom to coordinate case finding with the investigation into the cause of illness in these cases. Further investigations by the national authorities are ongoing to include more detailed exposure history, toxicology testing, and additional virological/microbiological tests. Guidance has been issued to experts to support a thorough investigation of suspected cases.
Further investigations and clinical and public health responses to the cases reported are also being undertaken in Ireland and Spain.
WHO risk assessment
The United Kingdom has reported a recent unexpected significant increase in cases of severe acute hepatitis of unknown aetiology in young children. Although the potential role of adenovirus and/or SARS-CoV-2 in the pathogenesis of these cases is one hypothesis, other infectious and non-infectious factors need to be fully investigated to properly assess and manage the risk.
As there is an ongoing increasing trend in cases in the United Kingdom over the past month together with more extensive case searching, it is very likely that more cases will be detected before the aetiology has been found (either biological, chemical or another agent (s)) and corresponding appropriate control and prevention measures have been taken.
WHO is closely monitoring the situation with the other countries and the United Kingdom and partners for cases with similar profiles.
WHO advice
Further work is required to identify cases both inside the United Kingdom and internationally. The priority is to determine the aetiology of these cases to guide further clinical and public health actions. Any epidemiological links between or among the cases might provide indications for tracking the source of illness. Temporal and geographical information of the cases, as well as their contacts, should be reviewed for potential risk factors.
While some cases tested positive for SARS-CoV-2 and/or adenovirus, genetic characterization of viruses should be undertaken to determine any potential associations between cases.
Countries are strongly encouraged to identify, investigate and report potential cases fitting the case definition.
International travel and trade: WHO does not recommend any restriction on travel and/or trade with the United Kingdom, or any other country where cases are identified, based on the currently available information.
– global bihari bureau
